Identifying Protein Biomarkers in Blood for Alzheimer's Disease

Background: At present, the main diagnostic methods for Alzheimer's disease (AD) are positron emission tomography (PET) scanning of the brain and analysis of cerebrospinal fluid (CSF) sample, but these methods are expensive and harmful to patients. Recently, more researchers focus on diagnosing...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Tianyi, Hu, Yang, Zang, Tianyi, Wang, Yadong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314983/
https://www.ncbi.nlm.nih.gov/pubmed/32626709
http://dx.doi.org/10.3389/fcell.2020.00472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314983/
https://www.ncbi.nlm.nih.gov/pubmed/32626709
http://dx.doi.org/10.3389/fcell.2020.00472

Ejemplares similares